Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines & 3rd Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts

 

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

The Neuroregeneration Program

The Neuroregeneration program focuses on studies to understand the basic mechanisms involved in neurodegeneration or neurologic injury in Parkinson’s disease, stroke and Alzheimer’s disease. Scientists use human induced pluripotent stem cells (iPSCs), which can develop into any cell type in the body, to study these disorders. The work is relevant to many additional disorders of the nervous system, such as autism, schizophrenia, major depression, bipolar disease, stroke, peripheral nerve disease and chronic pain. Some studies are working to crystallize or recreate proteins that may play crucial roles in cell death, develop stem cell-based therapies for neurologic disease and understand how cells communicate in Parkinson’s and Alzheimer’s diseases. 

The Neuroregeneration Program at Johns Hopkins’ Institute for Cell Engineering

Researcher Valina Dawson introduces the Neuroregeneration Program, where scientists study causes and potential treatments for conditions such as Parkinson’s and stroke.

 
 

Faculty

back to top button